KeyTec® TR-FRET PD1/PD-L1 Binding Assay kit（1,000 tests）

Founded in 2019 and based in Pudong New District, Shanghai, Shanghai VKEY Biotechnologies Co.,Ltd. (vkeybio.com) manufactures and provides services around TR-FRET and luminescence-based drug discovery assay kits under its KeyTec brand. Its extensive catalog includes cAMP and cytokine (TNFα, IL6) detection kits, tagged-antibody detection reagents (anti-HIS, anti-GST, anti-FLAG, anti-MYC, anti-HA), streptavidin and Protein A conjugates, hybridoma screening kits, kinase assay kits (CDKs, STK panels, ActRIIB), PROTAC-related cereblon and VHL binding kits, a PD1/PD-L1 binding assay kit, Fc-receptor binding kits (CD16a, CD64, FcRn), and luminescent 2D/3D cell viability detection kits. Categorized under drug target discovery and validation, the company holds ISO9001 certification and positions itself on brand strength, internationally recognized certification, experienced R&D personnel, delivery speed, production capacity and a rich product line, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.